Physicians want to see a steady, sustainable rate of weight loss while ensuring that patients continue eating adequate nutrients
While Zepbound, Wegovy, and Mounjaro have clinical evidence showing they may support weight loss, they are most effective when used as part of a medically supervised program
Diagnosed in February with FIP
1) Lean mass is the real conversationnot just weight loss In weight-loss interventions, some lean mass loss is expected
In another study in obese HFpEF patients, increased epicardial fat was associated with more marked hemodynamic changes: higher filling pressures, more severe pulmonary hypertension, and poorer functional capacity.35 In the EMPA-TROPISM25 clinical trial, a significant decrease in the total epicardial adipose tissue volume was seen after 6 months of empagliflozin treatment.30 This reduction was accompanied by an improvement in several inflammatory biomarkers, myocardial fibrosis, and aortic stiffness.30 Dapagliflozin, ipragliflozin, luseogliflozin, and canagliflozin, as well as some GLP-1 receptor agonists,34 have also led to reductions in epicardial adipose tissue, similar to the effects reported in EMPA-TROPISM